Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 41-50 of 197

Page
per page
  1. SB 747651A dihydrochloride
    B5660 SB 747651A dihydrochloride
    Summary: mitogen- and stress-activated kinase 1 (MSK1) inhibitor
      <20.77 mg/mL
  2. Ceftizoxime
    C6477 Ceftizoxime
      ≥76 mg/mL
  3. Cinromide
    C6610 Cinromide
      ≥42.5 mg/mL
  4. PIR 3.5
    B5541 PIR 3.5
    Summary: negative control of IPA 3, a Pak1 inhibitor
      ≥33.6 mg/mL
      insoluble in H2O
  5. Diammonium Glycyrrhizinate
    C6448 Diammonium Glycyrrhizinate
      insoluble in EtOH; ≥87 mg/mL
  6. Propacetamol hydrochloride
    C6486 Propacetamol hydrochloride
      ≥29.05 mg/mL
  7. 3PO
    B4939 3PO
    Summary: inhibitor of the PFKFB3 isozyme
      insoluble in H2O; ≥39.6 mg/mL
  8. Erythromycin estolate
    C6393 Erythromycin estolate
      ≥100 mg/mL
  9. Cyclic somatostatin
    C6438 Cyclic somatostatin
      insoluble in EtOH; ≥95.4 mg/mL
  10. Lomitapide
    B4885 Lomitapide
    Summary: MTP inhibitor, orally active
      ≥22.4 mg/mL

Items 41-50 of 197

Page
per page